Mean platelet volume in ocular Behçet's disease

Area of Science:

• Ophthalmology
• Rheumatology
• Hematology

Background:

• Ocular Behçet's Disease (BD) is a complex inflammatory condition affecting the eyes.
• Assessing disease severity and treatment efficacy in ocular BD requires reliable biomarkers.
• Mean platelet volume (MPV) has emerged as a potential inflammatory marker in various diseases.

Purpose of the Study:

• To investigate the utility of mean platelet volume (MPV) as an indicator of disease severity in patients with ocular Behçet's Disease (BD).
• To evaluate if MPV levels correlate with clinical improvement following immunosuppressive treatment in early-stage ocular BD.

Main Methods:

• A cohort of 30 newly diagnosed ocular BD patients with active uveitis was studied.
• MPV levels were measured serially in BD patients during active uveitis and at 1 and 3 months post-treatment.
• A control group of 34 healthy individuals was included for comparative MPV measurements.

Main Results:

• Initial MPV levels in active ocular BD patients (7.88 ± 1.14 fL) were significantly lower than in healthy controls (8.39 ± 0.66 fL).
• MPV levels in BD patients showed no significant fluctuations during the 3-month post-treatment follow-up period (7.71 ± 1.12 fL and 7.65 ± 1.04 fL).
• No significant changes in MPV were observed within the BD group during the study period.

Conclusions:

• Mean platelet volume (MPV) is not a reliable predictive laboratory test for assessing clinical improvement in early-stage ocular Behçet's Disease.
• MPV levels do not appear to correlate with disease severity or response to standard immunosuppressive therapy in this patient cohort.